Greater Cannabis Company (GCAN) Other Non-Current Liabilities (2016 - 2021)

Greater Cannabis Company's (GCAN) quarterly Other Non-Current Liabilities came in at $260905.0 in Q1 2021, down 84.69% year-on-year from $1.7 million in Q1 2020, and up 1395.93% quarter-over-quarter from $17441.0 in Q4 2020.

Greater Cannabis Company (GCAN) Other Non-Current Liabilities (2016 - 2021) Analysis & Trends

Greater Cannabis Company's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $260905.0 for Q1 2021.

  • On a quarterly basis, Other Non-Current Liabilities fell 84.69% year-over-year to $260905.0 in Q1 2021; TTM through Mar 2021 was $260905.0, a 84.69% decrease from a year earlier, with the FY2020 full-year figure at $17441.0, changed 0.0% from the prior year.
  • Other Non-Current Liabilities climbed to $260905.0 in Q1 2021 per GCAN's latest filing, from $17441.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.7 million in Q1 2020 and bottomed at $17441.0 in Q4 2019.
  • The 5-year median for Other Non-Current Liabilities is $259142.0 (2018), against an average of $343527.9.
  • Across the five-year window, Other Non-Current Liabilities soared 411.19% in 2020 and sank 84.69% in 2021, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $205403.0 in 2017, then tumbled by 47.21% to $108427.0 in 2018, then slumped by 83.91% to $17441.0 in 2019, then changed by 0.0% to $17441.0 in 2020, then jumped by 1395.93% to $260905.0 in 2021.
  • Per Business Quant, the three latest GCAN Other Non-Current Liabilities figures stand at $260905.0 (Q1 2021), $17441.0 (Q4 2020), and $325935.0 (Q3 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Greater Cannabis Company 292,929.85 292,929.85 -

Historic Data

Download Data
DateValue
Mar 31, 2021 260,905.00
Dec 31, 2020 17,441.00
Sep 30, 2020 325,935.00
Jun 30, 2020 539,686.00
Mar 31, 2020 1.70 Mn
Dec 31, 2019 17,441.00
Sep 30, 2019 251,367.00
Jun 30, 2019 251,367.00
Mar 31, 2019 333,432.00
Dec 31, 2018 108,427.00
Sep 30, 2018 482,667.00
Jun 30, 2018 270,502.00
Mar 31, 2018 259,142.00
Dec 31, 2017 205,403.00
Sep 30, 2017 124,731.00
Dec 31, 2016 100,000.00